BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Mar 15, 2015; 6(2): 296-303
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.296
Prediabetes diagnosis and treatment: A review
Nidhi Bansal
Nidhi Bansal, Department of Pediatrics, Section of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 77030, United States
Author contributions: Bansal N solely contributed to this work.
Conflict-of-interest: Bansal N has no conflict-of-interest.
Correspondence to: Nidhi Bansal, MD, MPH, Assistant Professor, Department of Pediatrics, Section of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children’s Hospital, 6701 Fannin St., Suite 1020, Houston, TX 77030, United States. nbansal@bcm.edu
Telephone: +1-832-8244104 Fax: +1-832-8253903
Received: August 29, 2014
Peer-review started: August 30, 2014
First decision: September 30, 2014
Revised: October 10, 2014
Accepted: December 29, 2014
Article in press: December 31, 2014
Published online: March 15, 2015
Processing time: 202 Days and 6.1 Hours
Core Tip

Core tip: Prediabetes is a state of intermediate hyperglycemia. While there are several controversies about the diagnosis of prediabetes, it remains an at-risk state for development of diabetes. Several adverse health outcomes have been associated with prediabetes. This review provides a detailed description of the current literature regarding diagnosis, health consequences and treatment of prediabetes and also provides an insight for clinical management.